Robyn K. Pollom

Similar efficacy and safety of <scp>LY2963016</scp> insulin glargine and insulin glargine ( <scp>L</scp> antus®) in patients with type 2 diabetes who were insulin‐naïve or previously treated with insulin glargine: a randomized, double‐blind controlled trial (the <scp>ELEMENT</scp> 2 study)

Julio Rosenstock, Priscilla Hollander, Anuj Bhargava et al. · Diabetes Obesity and Metabolism · 2015 · 108 citations · Full text

Efficacy and safety of <scp>LY2963016</scp> insulin glargine compared with insulin glargine ( <scp>L</scp> antus®) in patients with type 1 diabetes in a randomized controlled trial: the <scp>ELEMENT</scp> 1 study

Thomas Blevins, Dominik Dahl, Julio Rosenstock et al. · Diabetes Obesity and Metabolism · 2015 · 78 citations · Full text

Initiating insulin: How to help people with type 2 diabetes start and continue insulin successfully

William H. Polonsky, Joyce Arsenault, Lawrence Fisher et al. · International Journal of Clinical Practice · 2017 · 41 citations · Full text

Evaluation of immunogenicity of <scp>LY2963016</scp> insulin glargine compared with <scp>L</scp> antus® insulin glargine in patients with type 1 or type 2 diabetes mellitus

Liza L. Ilag, Mark A. Deeg, Timothy M. Costigan et al. · Diabetes Obesity and Metabolism · 2015 · 38 citations · Full text

Efficacy and safety of <scp>LY2963016</scp> insulin glargine in patients with type 1 and type 2 diabetes previously treated with insulin glargine

Irene Hadjiyianni, Dominik Dahl, LB Lacaya et al. · Diabetes Obesity and Metabolism · 2016 · 31 citations · Full text

Obesity, Metabolic Syndrome, Type 1 +12